The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis
Recruiting
Phase 4
Interventional Study
Septic Cardiomyopathy
Septic Shock
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 440 (estimated)
- Sponsor
- First Affiliated Hospital of Wannan Medical College · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study focuses on improving heart function in patients with life-threatening blood infections (septic shock). When the body fights severe infections, the heart sometimes struggles to pump blood effectively, which can lead to dangerous complications. Current treatments like intravenous fluids and blood pressure medications have limitations in protecting heart function.
This multicenter clinica…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 1\. Patients clinically diagnosed with septic shock must meet the diagnostic criteria of Sepsis 3.0;
* 2\. Age ≥ 18 years.
Exclusion Criteria:
* 1\. Pregnant or breastfeeding women;
* 2\. Individuals with a history of allergies or known hypersensitivity to Ginseng and Aconit…
Contacts